The argument for pharmaceutical policy

被引:9
|
作者
Traulsen, JM
Almarsdóttir, AB
机构
[1] Danish Univ Pharmaceut Sci, Dept Social Pharm, DK-2100 Copenhagen O, Denmark
[2] Univ Iceland, Fac Pharm, Reykjavik, Iceland
[3] AL BAS Pharmaceut Consultants Ltd, Reykjavik, Iceland
来源
PHARMACY WORLD & SCIENCE | 2005年 / 27卷 / 01期
关键词
health care; pharmaceutical policy; pharmacy administration;
D O I
10.1007/s11096-004-5151-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmaceutical policy is a global concern. It has become a hot political topic in most countries - developed as well as developing - and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint ( rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [1] The argument for pharmaceutical policy
    Janine Morgall Traulsen
    Anna Birna Almarsdóttir
    Pharmacy World and Science, 2005, 27 : 7 - 12
  • [2] Pharmaceutical Policy and the Lay Public*
    Janine M. Traulsen
    Anna Birna Almarsdóttir
    Pharmacy World and Science, 2005, 27 : 273 - 277
  • [3] Pharmaceutical policy and the lay public
    Traulsen, JM
    Almarsdóttir, AB
    PHARMACY WORLD & SCIENCE, 2005, 27 (04): : 273 - 277
  • [4] Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: A framework for influence
    Morrow N.C.
    Journal of Pharmaceutical Policy and Practice, 8 (1) : 1 - 6
  • [5] Challenges and opportunities for the development of a national pharmaceutical policy in Mexico
    Wirtz, Veronika J.
    Dreser, Anahi
    Heredia-Pi, Ileana
    SALUD PUBLICA DE MEXICO, 2013, 55 (03): : 329 - 336
  • [6] Pharmaceutical policy and the pharmacy profession
    Traulsen, AM
    Almarsdöttir, AB
    PHARMACY WORLD & SCIENCE, 2005, 27 (05): : 359 - 363
  • [7] Pharmaceutical Policy and the Pharmacy Profession*
    Janine M. Traulsen
    Anna Birna Almarsdóttir
    Pharmacy World and Science, 2005, 27 : 359 - 363
  • [8] Studying and evaluating pharmaceutical policy—becoming a part of the policy and consultative process
    Anna Birna Almarsdóttir
    Janine M. Traulsen
    Pharmacy World and Science, 2006, 28 : 6 - 12
  • [9] Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development
    Morrow N.C.
    Journal of Pharmaceutical Policy and Practice, 8 (1) : 1 - 6
  • [10] Studying and evaluating pharmaceutical policy -: becoming a part of the policy and consultative process
    Almarsdóttir, Anna Birna
    Traulsen, Janine M.
    PHARMACY WORLD & SCIENCE, 2006, 28 (01): : 6 - 12